Iron, copper and zinc content in bronchoalveolar lavage and lung tissue in experimental pulmonary emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 413s Year: 2001
Interleurin-4 and immunoglobulin E levels in bronchoalveolar lavage fluid and blood serum in patients with bronchial asthma and lung tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Comparison of serum and bronchoalveolar lavage fluid sialic acid levels between malignant and benign lung diseases Source: Eur Respir J 2002; 20: Suppl. 38, 465s Year: 2002
Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001
Chitotriosidase as a possible marker of sarcoidosis activity Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005
Iron and lipid content in serum and alveolar macrophages obtained by bronchoalveolar lavage in experimental pulmonary emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 414s Year: 2001
Iron and copper content in serum, pulmonary tissue, and bronchoalveolar lavage of rabbits on hypercholesterolemic diet Source: Eur Respir J 2005; 26: Suppl. 49, 103s Year: 2005
Serum lipid profile and iron content in serum and pulmonary tissue in experimental pulmonary emphysema Source: Annual Congress 2011 - Recent developments in COPD Year: 2011
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases Source: Eur Respir Mon; 2009: 46: 36–46 Year: 2009
Diagnostic value of total cell count in bronchoalveolar lavage fluid from patients with interstitial lung diseases Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Role of BALF in differential diagnosis of smoking related interstitial lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006
High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Cellular changes in BAL fluid may reflect immunity in patients with lung cancer Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression Year: 2005
Determination of IL-8 concentration and the activity of β-glucuronidase in BAL samples in children with inflammatory lung disease Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors Year: 2010
Increased activin-a expression in serum, BAL and bronchial tissue of asthmatic patients Source: Annual Congress 2009 - Novel approaches in asthma Year: 2009
The role of isoenzymes levels of ‘adenosine deaminase‘ in bronchoalveolar lavage fluid to determining activitiy of pulmonary tuberculosis Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005
Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia Year: 2020
Analysis of functional, radiologic, and bronchoalveolar lavage findings in patients with diffuse parenchymal lung diseases Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007